NEW YORK, April 24, 2018 /PRNewswire/ --
Cancer Genetics, Inc. (CGIX)
Lifshitz & Miller announces investigation into possible securities law violations in connection with Cancer Genetics' announcement that it "had a material weakness in internal controls over financial...